The “Goldilocks principle” applies to mutant APC-driven and mutant BRAF-driven intestinal tumorigenesis: a threshold of oncogenic signaling needs to be reached for dysplastic lesions to form, but optimum tumor development requires “just-right” levels of oncogenic signaling, with too much being as detrimental as too little. The gene discussed is BRAF; the disease is neoplasm.